semaglutide vs wegovy for weight loss Zepbound GLP-1 vs Wegovy: What's the Difference Semaglutide Tablets vs. Injection: Effective

3 Months $1200

NRD per 1000 people 5.57 (6.61 to 4.53)), cannabis use (0.86 (0.81 to 0.90), NRD 2.25 (3.00 to 1.50)), cocaine use (0.80 (0.72 to 0.88), NRD 0.97 (1.37 to 0.57)), nicotine use (0.80 (0.74 to 0.87), NRD 1.64 (2.19 to 1.09)), and opioid use (0.75 (0.67 to 0.85), NRD 0.86 (1.19 to 0.52)), and other SUDs (0.87 (0.81 to 0.94), NRD 1.12 (1.68 to 0.55)) and composite outcome of all incident SUDs (0.86 (0.83 to 0.88), NRD 6.61 (7.95 to 5.26))

Thats no longer fringe interest - thats cultural adoption

Three months after semaglutide went off-patent, the excitement around the weight-loss drug is tapering off while tirzepatide, marketed as Mounjaro, is regaining its GLP-1 market share